Sister's ovary tissue may restore fertility in early menopause

NCT ID NCT06673004

First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 2 times

Summary

This study tests whether transplanting ovarian tissue from a sister can restore fertility and hormone production in women with premature ovarian failure (early menopause). Ten women will receive tissue from their non-identical sister, along with immunosuppressive drugs to prevent rejection. The goal is to see if periods return and if pregnancy is possible.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ovarian tissue transplant
What this could lead to
If successful, this could offer a way for women with premature ovarian failure to restore fertility and hormone function without needing an egg donor.
What could go wrong
This is a very small, early study with only 10 participants. The transplant requires lifelong immunosuppression, which carries risks like infection and organ damage. Success is not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOCRINE FEMALE INFERTILITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio, 44106, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.